Lack of efficacy of a nicotine transdermal treatment on motor and cognitive deficits in Parkinson's disease
- 1 January 2004
- journal article
- clinical trial
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 28 (1) , 31-39
- https://doi.org/10.1016/s0278-5846(03)00172-6
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Quantitative Analysis of Rapid Pointing Movements in Cree Subjects Exposed to Mercury and in Subjects with Neurological DeficitsEnvironmental Research, 1999
- Induction of a Transient Dysexecutive Syndrome in Parkinson’s Disease using a~Subclinical Dose of ScopolamineBehavioural Neurology, 1999
- Analysis of Rapid Alternating Movements in Cree Subjects Exposed to Methylmercury and in Subjects with Neurological DeficitsEnvironmental Research, 1999
- Pharmacology of Nicotine: Addiction and TherapeuticsAnnual Review of Pharmacology and Toxicology, 1996
- Beneficial effects of nicotine and cigarette smoking: the real, the possible and the spuriousBritish Medical Bulletin, 1996
- The short-term effect of nicotine chewing gum in patients with parkinson's diseasePsychopharmacology, 1995
- Comparative Alterations of Nicotinic and Muscarinic Binding Sites in Alzheimer's and Parkinson's DiseasesJournal of Neurochemistry, 1992
- COGNITIVE IMPAIRMENT IN EARLY, UNTREATED PARKINSON'S DISEASE AND ITS RELATIONSHIP TO MOTOR DISABILITYBrain, 1991
- Dissociation of the apparent relationship between nicotine tolerance and up-regulation of nicotinic receptorsBrain Research Bulletin, 1990
- Cigarette smoking and Parkinson's diseaseNeurology, 1986